Annexin Pharmaceuticals (Sweden) Today
| ANNX Stock | SEK 0.27 0.01 3.57% |
Performance0 of 100
| Odds Of DistressOver 68
|
Annexin Pharmaceuticals is selling for under 0.27 as of the 23rd of April 2024; that is -3.57 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.27. Annexin Pharmaceuticals has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Annexin Pharmaceuticals AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.. The company has 154.5 M outstanding shares. More on Annexin Pharmaceuticals AB
Moving against Annexin Stock
| 0.47 | VITR | Vitrolife AB | PairCorr |
| 0.47 | XSPRAY | XSpray Pharma AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Annexin Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Annexin Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Annexin Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Annexin Pharmaceuticals AB (ANNX) is traded on Stockholm Exchange in Sweden and employs 4 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 189.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Annexin Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Annexin Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Annexin Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 154.5 M outstanding shares.
Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Annexin Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAnnexin Pharmaceuticals retains a total of 154.5 Million outstanding shares. Annexin Pharmaceuticals AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Annexin Ownership Details
Annexin Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Annexin Pharmaceuticals jumping above the current price in 90 days from now is about 27.22%. The Annexin Pharmaceuticals AB probability density function shows the probability of Annexin Pharmaceuticals stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.8153. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Annexin Pharmaceuticals will likely underperform. Additionally, annexin Pharmaceuticals AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Annexin Pharmaceuticals to move above the current price in 90 days from now is about 27.22 (This Annexin Pharmaceuticals AB probability density function shows the probability of Annexin Stock to fall within a particular range of prices over 90 days) .
Annexin Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Annexin Pharmaceuticals market risk premium is the additional return an investor will receive from holding Annexin Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Annexin Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Annexin Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Annexin Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.01 | |||
| Semi Deviation | 3.95 | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.06 |
Annexin Stock Against Markets
Picking the right benchmark for Annexin Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Annexin Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Annexin Pharmaceuticals is critical whether you are bullish or bearish towards Annexin Pharmaceuticals AB at a given time. Please also check how Annexin Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Annexin Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Annexin Pharmaceuticals Corporate Management
Elected by the shareholders, the Annexin Pharmaceuticals' board of directors comprises two types of representatives: Annexin Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Annexin. The board's role is to monitor Annexin Pharmaceuticals' management team and ensure that shareholders' interests are well served. Annexin Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Annexin Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ulrika Harndahl | Head CMC | Profile | |
| Anna MD | Chief Officer | Profile | |
| Susan Suchdev | Chief Officer | Profile | |
| Henrik Palm | Chief Officer | Profile | |
| Anders MD | Chief Officer | Profile | |
| MSc LLM | Therapy Ophthalmology | Profile |
How to buy Annexin Stock?
Before investing in Annexin Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Annexin Pharmaceuticals. To buy Annexin Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Annexin Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Annexin Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Annexin Pharmaceuticals AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Annexin Pharmaceuticals AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Annexin Pharmaceuticals AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Annexin Pharmaceuticals AB?
The danger of trading Annexin Pharmaceuticals AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Annexin Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Annexin Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Annexin Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annexin Pharmaceuticals AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Annexin Stock analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |